Zusammenfassung
Es muß hier nicht betont werden, daß Psoriasis vulgaris eine der bedeutendsten Hauterkrankungen ist, sie gehört zum Alltagsgeschäft der Dermatologie. Während die Diagnose einer Psoriasis zumindest in ihrer klassischen Ausprägung meist noch relativ einfach ist, kann bereits ihre Behandlung trotz der großen therapeutischen Fortschritte der letzten Jahre außerordentlich schwierig sein. Wirklich schwer ist es auch heute noch, die Psoriasispathogenese zu erklären. Dabei ist eigentlich keine dermatologische Erkrankung so intensiv beforscht worden und dabei dennoch so unerklärt geblieben wie eben die Psoriasis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Koebner H (1872) Über die Ätiologie der Psoriasis. Jahresbericht der Schlesischen Gesellschaft Vaterl Kultur 50: 210–211
Munro F (1898) Note sur lhistopathologie du psoriasis. Annales
Civatte A (1924) Psoriasis and seborrhoeic eczema: pathological anatomy and diagnostic histology of the two dermatoses. Br Dermatol 36: 461–476
Winfield JM (1916) Psoriasis as sequel to acute inflammations of the tonsils: clinical note. J Cut Dis 34:441–443
Hammerström S, Hamberg M, Samuelsson B, Duell EA, Stawiski M, Voorhees JJ (1975) Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE), prostaglandin E2 and prostaglandin F2α in epidermis of psoriasis: evidence of perturbed regulation of arachidonic acid levels in psoriasis. Proc Natl Acad Sci USA 72: 5130–5134
Kragballe K, Voorhees JJ (1985) Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation. Acta Derm Venereol Suppl (Stockh) 120: 12–17
Schröder JM, Christophers E (1986) Identifikation of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87: 53–58
Van Scott EJ, Ekel TM (1963) Kinetics of hyperplasia in psoriasis. Arch Dermatol 88: 373–380
Rüssel TJ, Schultes LM, Kuban DJ (1972) Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med 287: 738–740
White SH, Newcomer VD, Mickey MR, Terasaki PI (1972) Disturbance of HL-A antigen frequency in psoriasis. N Engl J Med 287: 740–742
Hoede K (1957) Zur Frage der Erblichkeit der Psoriasis. Hautarzt 8: 433–438
Mueller W, Hermann B (1976) Cyclosporin A for psoriasis. N Engl J Med 301: 355
Prinz JC, Braun-Falco O, Meurer M, Daddona P, Reiter C, Rieber EP, Riethmüller G (1991) Chimeric CD4 monoclonal antibody in the treatment of generalized pustular psoriasis. Lancet 338: 320–321
Riethmüller G, Rieber EP, Kiefersauer S, Prinz JC, Van der Lübbe P, Meiser B, Breedveld F, Eisenburg J, Krüger K, Deusch K, Sanders M, Reiter C (1992) From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease. Immunol Rev 129: 81–104
Braun-Falco O, Burg G (1970) Das entzündliche Infiltrat bei Psoriasis vulgaris. Arch Klin Exp Dermatol 236: 297–314
Braun-Falco O, Christophers E (1974) Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch 251: 95–110
Mosmann TR, Bond MW, Coffman RL, Ohara J, Paul WE (1986) T cells and mast cell lines respond to B cell stimulatory factor-i. Proc Natl Acad Sci USA 83: 5654–5658
Valdimarsson H, Baker BS, Jonsdottir I, Fry L (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 7: 256–259
Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM (1986) Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of psoriatic plaques. J Exp Med 164: 1013–1028
Bjerke JR, Matre R (1983) Demonstration of la-like antigens on T lymphocytes in lesions of psoriasis, lichen planus and discoid lupus erythematosus. Acta Dermatol Venereol 63:103–107
Baker BS, Swain AF, Fry L, Valdimarsson H (1984) Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 110: 555–564
Baker BS, Swain AF, Valdimarsson H, Fry L (1984) T cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol 110: 37–44
Kitano Y, Okada N (1983) Separation of the epidermal sheet by dispase. Br J Dermatol 108: 555–560
Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G (1994) T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro. Eur J Immunol 24: 593–598
Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD (1995) Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 95: 317–327
Vollmer S, Menssen A, Trommler P, Schendel D, Prinz JC (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24: 2377–2382
Hancock GE, Kaplan G, Cohn ZA (1988) Keratinocyte growth regulation by the products of immune cells. J Exp Med 168: 1395–1402
Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates the proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367–6371
Barker JNWN, Allen HM, McDonald DM (1989) The effect of in vivo IFN-y on the distribution of LFA-i and ICAM-i in normal human skin. J Invest Dermatol 93: 439–443
Morhenn VB, Abel EA, Mahrle G (1982) Expression of HLA-DR-antigen in skin from patients with psoriasis. J Invest Dermatol 62: 165–168
Nickoloff BJ, Karabin GD, Barker JNWN (1991) Localization of IL-8 and its inducer TNF-a in psoriasis. Am J Pathol 138: 129–140
Matsushima K, Oppenheim JJ (1989) Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-i and TNF. Cytokines 1: 2–13
Schröder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E (1993) IL-ia or TNF-a stimulate release of NAP-i/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 144: 2223–2232
Cox AJ (1977) Mast cells in psoriasis. In: Farber EM, Cox AJ (eds) Psoriasis. Yorke Medical Books, New York, pp 36–43
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clones. I. Definition according to profiles of lympho- kine activities and secreted proteins. J Immunol 136: 2348–2357
Cher DJ, Mosmann TR (1987) Two types of murine helper T cell clones. II. Delayed-type hypersensitivity is mediated by TH1-clones. J Immunol 138: 3688–3694
Martin R, Howell MD, Jaraquemada D, Flerlage D, Richert J, Brostoff S, Long EO, McFarlin DE, McFarland HF (1991) A myelin basic protein peptide is recognized in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173: 19–24
Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimenkovitz R, Sherrit M, Rothbard J, Bernard CCA, Steinman L (1993) Selection for T cell receptor Vß-Dß-Jß gene rearrangements with specificity for a myelin basic protein in brain lesions of multiple sclerosis. Nature 362: 68–70
Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, Trucco M (1994) Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371: 351–355
Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A (1991) Evidence of a limited variability of antigen receptors in intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 325: 238–244
Williams WV, Fang Q, Demarco D, von Feldt J, Zurier RB, Weiner DB (1992) Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium. J Clin Invest 90: 326–333
Mantegazza R, Andreetta F, Bernasconi P, Baggi F, Oksenberg JR, Simoncini O, Mora M, Cornelio F, Steinman L (1993) Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. J Clin Invest 91: 2880–2886
Stamenkovic I, Stegagno M, Wright KA, Krane SM, Amento EP, Colvin RB, Duquesnoy RJ, Kurnick JT (1988) Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci USA 85: 1179–1183
Grom AA, Thompson SD, Luyrink L, Passo M, Choi E, Glass DN (1993) Dominant T-cell-receptor ß chain variable region V(314+ clones in juvenile rheumatoid arthritis. Proc Natl Acad Sci USA 90: 11104–11108
Lewis HM, Baker BS, Bokth S, Powles AV, Garioch JJ, Valdimarsson H, Fry L (1993) Restricted T cell receptor- ß gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 129: 514–520
Leung DYM, Walsh P, Giorno R, Norris DA (1993) A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 100: 225–228
Valdimarsson H, Baker BS, Jonsdottir I, Powles AV, Fry L (1995) Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16: 145–149
Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989) Interaction of Staphylococcus aureus toxin “superantigens” with human T cells. Proc Natl Acad Sci USA 86: 8941–8945
Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, Posnett DN, Choi Y, Marrack P (1989) V beta-specific stimulation of human T cells by staphylococcal toxins. Science 244: 811–813
Menssen A, Trommler P, Vollmer S, Schendel D, Albert E, Gürtler L, Riethmüller G, Prinz JC (1995) Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 155: 4078–4083
Chang JCC, Smith LR, Froning KJ, Schwabe BJ, Laxer JA, Caralli LL, Kurland HH, Karasek MA, Wilkinson DI, Carlo DJ, Brostoff SW (1994) CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vß3 and/ or Vß13.i genes. Proc Natl Acad Sci USA 91: 9282–9286
McFadden JH, Valdimarsson H, Fry L (1991) Cross-reactivity between streptococcal M surface antigen and human skin. Br J Dermatol 125: 443–447
Robinson JH, Kehoe MA (1992) Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today 13: 362–367
Swerlick RA, Cunningham MW, Hall NK (1986) Monoclonal antibodies crossreactive with group A streptococci and normal and psoriatic human skin. J Invest Dermatol 87: 367–371
Fischetti VA (1989) Streptococcal M protein: molecular design and biological behaviour. Clin Microbiol Rev 2: 285–314
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Prinz, J.C. (1997). Psoriasis vulgaris — der lange Weg zur Autoimmunerkrankung. In: Plewig, G., Przybilla, B. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60534-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-60534-5_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64448-1
Online ISBN: 978-3-642-60534-5
eBook Packages: Springer Book Archive